Trial intelligence / Profile preview

Paracetamol and Diclofenac for Acute Limb Injury Pain

NCT04199572Phase 4Completed

Sponsor
Hamad Medical Corporation
Start
Oct 2022
Primary completion
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of acetaminophen in acute pain (3 arms), sponsored by Hamad Medical Corporation. Primary endpoint: Mean pain reduction on Numerical Rating Scale. Started Oct 2022; status: completed.

02

Drugs

acetaminophen
03

Conditions

acute pain

Beyond the preview

Go deeper on NCT04199572.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04199572.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call